Responses
Clinical and epidemiological research
Extended report
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
Compose a Response to This Article
Other responses
No responses have been published for this article.